Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Organisation › Details

Spark Therapeutics Inc.

At Spark Therapeutics, a fully integrated, commercial company committed to discovering, developing and delivering gene therapies, we challenge the inevitability of genetic diseases, including blindness, hemophilia, lysosomal storage disorders and neurodegenerative diseases. We have successfully applied our technology in the first FDA-approved gene therapy in the U.S. for a genetic disease, and currently have three programs in clinical trials, including product candidates that have shown promising early results in patients with hemophilia. At Spark, we see the path to a world where no life is limited by genetic disease. *

 

Period Start 2013-10-01 established
  Predecessor Children’s Hospital of Philadelphia (CHOP)
Products Industry gene therapy
  Industry 2 adeno-associated viral vector (AAV vector)
     
Region Region Philadelphia, PA
  Country United States (USA)
  Street 3737 Market Street
  City 19104 Philadelphia, PA
  Tel +1-215-220-9300
    Address record changed: 2018-11-26
     
Basic data Employees n. a.
     
    * Document for �About Section�: Spark Therapeutics, Inc.. (11/23/18). "Press Release: European Commission Approves Spark Therapeutics’ Luxturna (voretigene neparvovec), a One-time Gene Therapy for Inherited Retinal Disease Caused by Confirmed Biallelic RPE65 Mutations". Philadeliphia,
     
   
Record changed: 2019-04-23

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

More documents for Spark Therapeutics Inc.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px




» top